Filing Details
- Accession Number:
- 0001381980-13-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-12 17:27:48
- Reporting Period:
- 2013-11-08
- Filing Date:
- 2013-11-12
- Accepted Time:
- 2013-11-12 17:27:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1274644 | Ocera Therapeutics Inc. | OCRX | Pharmaceutical Preparations (2834) | 631192270 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1381980 | S Nina Kjellson | C/O Interwest Partners 2710 Sand Hill Road, Suite 200 Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-11-08 | 422,238 | $0.00 | 1,248,064 | No | 4 | P | Indirect | By Partnership |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Partnership |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant | Acquisiton | 2013-11-08 | 84,448 | $0.00 | 84,448 | $7.66 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
84,448 | 2013-11-08 | 2013-11-05 | No | 4 | P | Indirect |
Footnotes
- Each unit, consisting of one share of common stock and a warrant to purchase 0.2 of a share of common stock, was sold for a total purchase price of $7.105 per unit.
- The shares are held by InterWest Partners IX, LP ("IW9"). InterWest Management Partners IX, LLC ("IMP9") the general partner of IW9, has sole voting and investment control over the shares held by IW9. The Reporting Person serves as a Venture Member of IMP9 and may be deemed to share voting and investment control with respect to the shares held by IW9. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of her pecuniary interest therein.